Abstract | OBJECTIVE: STUDY DESIGN: This study was a retrospective review of 96 women who were diagnosed with lichen sclerosus with a follow-up of at least 1 year. Of these 96 women, 47 were treated with the topical application of CLB and 49 were treated with the topical application of MMF. All patients received treatment for 8 weeks. The drug was administered once daily for 4 weeks and then twice weekly for another 4 weeks in combination with a moisturizing cream that was continued as maintenance therapy. Subsequently, a topical steroid was applied on an as-needed basis if symptoms recurred. Follow-up visits were scheduled at 3, 6, and 12 months. The primary endpoint was the clinical response of the patients. RESULTS: A mean of 77.3% of the patients were defined as responders at the 12-month observation, without any significant difference between the 2 treatment groups (CLB mean 73% vs MMF mean 81.6%, p = .2). A pronounced improvement in itching was observed after 3 months of treatment in the MMF group (p = .04), whereas the other symptoms were not significantly different between the 2 groups. CONCLUSIONS: This study indicates that CLB 0.05% and MMF 0.1% in a short protocol regimen are effective, safe, and reliable treatments for VLS, with no significant difference between the 2 steroids in their efficacy. However, a moisturizing cream should be an integral part of the treatment.
|
Authors | Filippo Murina, Subhia Rehman, Stefania Di Francesco, Valeria Mantegazza, Raffaele Felice, Vanda Bianco |
Journal | Journal of lower genital tract disease
(J Low Genit Tract Dis)
Vol. 19
Issue 2
Pg. 149-51
(Apr 2015)
ISSN: 1526-0976 [Electronic] United States |
PMID | 25023331
(Publication Type: Clinical Study, Comparative Study, Journal Article)
|
Chemical References |
- Dermatologic Agents
- Mometasone Furoate
- Clobetasol
|
Topics |
- Administration, Topical
- Adult
- Aged
- Clobetasol
(adverse effects, therapeutic use)
- Dermatologic Agents
(adverse effects, therapeutic use)
- Female
- Follow-Up Studies
- Humans
- Middle Aged
- Mometasone Furoate
(adverse effects, therapeutic use)
- Retrospective Studies
- Treatment Outcome
- Vulvar Lichen Sclerosus
(drug therapy)
|